DeutschNewstral
Article
Financial Times on 2023-01-09 12:52
Bayer AG: Jeff Ubben takes $500mn stake in Bayer
Related news
- FActivist investor Jeff Ubben to join Bayer’s supervisory boardft.com
- Investor Jeff Ubben questions ESG funds in second act as activistFinancial Times
- FJeff Ubben quits ValueAct for social investingft.com
- Bayer embraces activist Ubben with place on its sustainability councilFinancial Times
- BActivist Investor Jeff Ubben Departs ValueAct to Focus on ESGbarrons.com
Insider Jeff Ubben Feeds Yacktman's Twenty-First Century FoxForbes- BEnviva Stock Tumbled. Jeff Ubben and Insiders Bought Up Shares.2 min readbarrons.com
- FActivist investor Elliott builds stake in Bayerft.com
- FJeff Ubben/ESG: flip flopft.com
- Bayer AG: Bayer chief blasts conglomerate’s performance as ‘unacceptable’Financial Times
- Bayer AG: Bayer drug setback adds to new CEO’s problems Financial Times
- FValueAct takes stake in Smiths Groupft.com
- M‘Finance is, like, done. Everybody’s bought everybody else with low-cost debt’ says ValueAct founder Jeff Ubben — ‘Elizabeth Warren was right’marketwatch.com
- Costcutter owner Bestway takes 3.45% stake in Sainsbury’sFinancial Times
- Billionaire Agnelli family takes 15% stake in PhilipsFinancial Times
- Bayer AG: Bayer chief hits out at US legal system after weedkiller fightFinancial Times
[Ticker] Soros buys €500mn stake in Santandereuobserver.com
Bayer Pharma AG v. Watson Labs., Inc.jdsupra.com